Specificity, Inc. Reports Worsening Q1 Losses and Persistent Going Concern Doubts Amid Dilutive Financing
Summary
Specificity, Inc. reported a 20% revenue decline and increased net losses for Q1 2026, alongside a persistent going concern warning and material weaknesses in internal controls, highlighting severe financial challenges and reliance on dilutive financing.
Key Events
-
Worsening Financial Performance
Net revenue decreased by 20% to $243,850 for Q1 2026 compared to $298,050 in Q1 2025, leading to an increased net loss of $182,397 from $140,216 in the prior year period. Cash used in operations was $(90,558) compared to $12,777 provided in the prior year.
-
Persistent Going Concern Warning
The company continues to express substantial doubt about its ability to continue as a going concern for the next 12 months, citing an accumulated deficit of $8.8 million and a working capital deficit of $1.26 million as of March 31, 2026.
-
Material Weaknesses in Internal Controls
Management concluded that disclosure controls and procedures were not effective due to material weaknesses, including a lack of segregation of duties, inadequate document retention, heavy reliance on outside consultants, and absence of board/audit committee oversight.
-
Continued Dilutive Capital Raises
The company continues to rely on dilutive financing, including a Strata Purchase Agreement under which it issued 400,000 shares for $24,000 in Q1 2026 (at $0.06/share) and an additional 200,000 shares for $30,000 on June 3, 2026, to cover operating expenses.
Analysis
This quarterly report reveals a significant deterioration in Specificity, Inc.'s financial health, with a 20% decline in revenue and a larger net loss compared to the prior year. The company continues to operate with an extremely low cash balance and a worsening working capital deficit, explicitly reiterating substantial doubt about its ability to continue as a going concern. Furthermore, the filing confirms persistent material weaknesses in internal controls and an ongoing reliance on highly dilutive capital raises, such as the Strata Purchase Agreement, to fund operations. These factors collectively indicate severe financial distress and significant operational risks.
At the time of this filing, SPTY was trading at $0.45 on OTC in the Trade & Services sector, with a market capitalization of approximately $7.9M. The 52-week trading range was $0.02 to $1.40. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.